2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Recurrent Non-Squamous Non-Small Cell Lung Carcinoma: new trials by email Literature Review of Recurrent Non-Squamous Non-Small Cell Lung Carcinoma trials Research Report on Recurrent Non-Squamous Non-Small Cell Lung Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) Rucaparib - Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation | Phase 2 | Completed | SWOG Cancer Research Network | 64 | 2019-04-16 | 2025-05-21 |
| Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations Pembrolizumab, Trametinib - KRAS Gene Mutation, Metastatic Non-Squamous Non-Small Cell Lung Carcinoma | Phase 1 | Completed | Jonathan Riess | 15 | 2018-06-26 | 2025-05-21 |
Carcinoma, Non-Small-Cell Lung (2) · Adenocarcinoma of Lung (1) · Lung Neoplasms (1)
Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Lung Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Adenocarcinoma (1) · Carcinoma (1) · Lung Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
pembrolizumab (1) · rucaparib (1) · trametinib (1)
Jonathan Riess (1) · SWOG Cancer Research Network (1)
United States (2)
Jonathan Riess (1) · Jonathan W Riess (1)
P30CA093373 (1), U10CA180888 (1)